What is the next step for a 35-year-old patient with ulcerative colitis (UC) who started on Rituximab (rituximab) and now has constant chest pain for a few weeks with a negative electrocardiogram (EKG) and negative troponin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation of Constant Chest Pain in a 35-Year-Old UC Patient on Rituximab

The next step is to obtain a chest X-ray and consider advanced cardiac imaging (echocardiography or cardiac CT) to evaluate for rituximab-associated cardiovascular complications, pericarditis, or other life-threatening causes, while simultaneously assessing for musculoskeletal causes through physical examination with specific palpation of costochondral joints.

Immediate Diagnostic Priorities

Rule Out Life-Threatening Cardiac Causes

While the initial EKG and troponin are negative, this does not exclude all serious cardiac pathology in a patient on rituximab:

  • Rituximab carries specific cardiovascular risks including ventricular fibrillation, myocardial infarction, and cardiogenic shock that may not present with typical biomarker elevation initially 1
  • Perform transthoracic echocardiography to evaluate for pericarditis (which can present with constant chest pain worsened in supine position), stress cardiomyopathy, or valvular abnormalities 2
  • Obtain chest X-ray immediately to evaluate for pneumonia, pneumothorax, pleural effusion, or widened mediastinum suggesting aortic pathology 2

Consider Rituximab-Specific Complications

Rituximab has documented gastrointestinal and cardiovascular toxicities that must be considered:

  • Rituximab-associated cardiovascular adverse reactions can manifest as chest pain and irregular heartbeats, requiring immediate evaluation 1
  • While rituximab-associated colitis is more common (4% incidence), cardiovascular complications including myocardial infarction have been reported 3, 1
  • The median time from rituximab treatment to adverse events is approximately 181 days, making this temporally plausible 3

Systematic Evaluation Algorithm

Step 1: Focused Physical Examination (Perform Immediately)

  • Palpate costochondral joints systematically - tenderness here suggests costochondritis, which is the most common cause of nontraumatic musculoskeletal chest wall pain (42%) 4
  • Assess for pericardial friction rub - pericarditis presents with constant pain increased in supine position 2
  • Check for pulse differentials and blood pressure in both arms - aortic dissection can present with severe constant pain 2
  • Auscultate for murmurs - new murmurs may indicate valvular complications 2

Step 2: Laboratory and Imaging Workup

Order the following tests based on initial examination:

  • Repeat high-sensitivity troponin at 3 hours if initial presentation was within 6 hours of pain onset, as serial troponins improve sensitivity for acute coronary syndrome 2
  • Chest X-ray to evaluate for pneumonia (fever, egophony, dullness to percussion), pneumothorax (unilateral absent breath sounds), or pleural disease 2
  • Transthoracic echocardiography if any hemodynamic disturbances, new murmurs, or concern for pericarditis 2
  • Consider D-dimer if pulmonary embolism is suspected (tachycardia, dyspnea, pleuritic pain) 2

Step 3: Risk Stratification

For a 35-year-old with constant chest pain for weeks and negative initial workup:

  • The duration (weeks) and constant nature makes acute coronary syndrome less likely but does not exclude it 2
  • Low-risk features include: reproducible pain with palpation, absence of radiation, no associated dyspnea or diaphoresis 2, 5
  • High-risk features requiring urgent evaluation include: ongoing severe pain, hemodynamic instability, new ECG changes, or elevated troponin 2

Differential Diagnosis Priority List

Most Likely Diagnoses to Evaluate:

  1. Costochondritis - characterized by tenderness to palpation of costochondral joints, often affects ribs 6-7, pain may be stinging or pressing 4
  2. Pericarditis - constant pain worsened supine, may have friction rub, can be associated with inflammatory conditions 2
  3. Rituximab-associated cardiovascular toxicity - documented risk of myocardial infarction and chest pain 1
  4. Gastroesophageal reflux disease - common cause of constant chest discomfort 2, 5
  5. Anxiety/panic disorder - can present with chest pain; screen with two-item questionnaire 6

Less Common but Critical to Exclude:

  • Pulmonary embolism - rituximab patients may have increased thrombotic risk; one case of pulmonary embolism was reported in rituximab trials 7
  • Pneumonia - rituximab increases infection risk; look for fever, productive cough, focal findings 1
  • Aortic dissection - severe constant pain with abrupt onset, pulse differential 2

Management Based on Findings

If Costochondritis is Confirmed:

  • Initiate NSAIDs for 1-2 weeks (if no contraindications) 4
  • Consider low-dose colchicine if symptoms persist despite NSAID therapy 4
  • Apply ice or heat packs as adjunctive therapy 4
  • Reassess if symptoms persist to rule out other causes 4

If Cardiac Cause Cannot Be Excluded:

  • Refer to emergency department immediately for patients with high-risk features 2
  • Consider cardiac stress testing or coronary CT angiography for intermediate-risk patients once acute coronary syndrome is excluded 2, 5
  • Admit for observation if ongoing symptoms despite negative initial workup, particularly given rituximab's cardiovascular risks 1

Critical Pitfalls to Avoid

  • Do not dismiss constant chest pain lasting weeks as benign without thorough evaluation, especially in a patient on immunosuppressive therapy 1
  • Do not rely solely on initial negative troponin - serial troponins and advanced imaging may be needed 2
  • Do not overlook rituximab-specific complications including cardiovascular toxicity and increased infection risk 1
  • Do not assume musculoskeletal cause without documenting reproducible tenderness on examination 4, 5
  • Remember that relief with nitroglycerin is not diagnostic of cardiac ischemia and can occur with esophageal spasm 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical Features of Rituximab-associated Gastrointestinal Toxicities.

American journal of clinical oncology, 2019

Guideline

Costochondritis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Chest Pain in Adults: Outpatient Evaluation.

American family physician, 2020

Research

Diagnosing the cause of chest pain.

American family physician, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.